Healthy Data Management: Essential Strategies for Governing Phi, Pii, and Highly Sensitive Data during an Acquisition or Divestiture

The merger and divestiture process for any type of company raises issues of data management and protection, particularly with the ease employees use technology to collect, store, and use data. Due to the nature of the confidential data that health care, life sciences, and pharmaceutical companies create and retain, these types of organizations face higher standards and specific issues related to the retention and protection of data when engaged in the merger or divestiture transaction process. Companies must balance the demand for access and sharing of data to meet business needs with legal and compliance obligations to protect highly sensitive data.

Join us for a 60-minute panel discussion covering the information governance life cycle for health care, life sciences, and pharmaceutical companies, from identification of sensitive data to storing and protecting that data during mergers and divestitures. You will gain insight on how to effectively manage and store your data as well as tips for developing an information governance program designed specifically to handle the type of sensitive data your health-focused company maintains.

Educational Objectives:

  • Data management considerations for companies responsible for maintaining personally identifiable information (PII), protected health information (PHI), and confidential or sensitive data.
  • Unique issues that arise when highly sensitive data is involved during the merger and divestiture transaction process.
  • Strategies to develop effective policies and procedures for data life cycle management.

Who would benefit most from attending this program?

C-suite executives and in-house counsel from life sciences, pharmaceutical, and health care companies; outside counsel advising these companies; litigation support professionals.

Panelists:

  • Jeffrey D. Bridges Director, Information Governance, NA, Boehringer Ingelheim USA
  • James Arnold Managing Director, U.S. Forensic Technology Services, KPMG
  • Elliot Golding Counsel, Crowell & Moring
  • Brian Tuemmler Information Governance Product Manager, Nuix (moderator)

Brian Tuemmler

Information Governance Program Architect

Brian Tuemmler joined Nuix in 2013 as Information Governance Program Architect helping IG practitioners and sponsors set up and manage enterprise governance programs through methodology, training, tools and software.

Brian has more than 20 years’ experience in the industry including speaking engagements and published articles for ARMA, AIIM and MER.

 

Read More